Tuesday, September 27, 2022 | Back issues
Courthouse News Service Courthouse News Service


Teva Pharmaceuticals claims AstraZeneca's and IPR Pharmaceuticals' anti-cholesterol blockbuster drug, Crestor, violates its patented "Stable Pharmaceutical Compositions Containing 7-Substituted-3,5-Dihydroxyheptanoic Acids or 7-Substituted-3,5-Dihydroxyheptenoic Acids," in Philadelphia Federal Court.

Read the Top 8

Sign up for the Top 8, a roundup of the day's top stories delivered directly to your inbox Monday through Friday.